Research Insight
Novartis, Intellia and Caribou to develop new medicines and...
Swiss drug-maker Novartis has entered collaboration and licensing agreements with Intellia Therapeutics to develop new medicines using CRISPR genome editing technology and Caribou Biosciences for...
Research Insight
New technology may detect nucleic acid biomarkers of cancer
A new technique has been developed utilizing nanotechnology to detect disease biomarkers in the form of nucleic acids.The proof-of-concept study came from a team of...
Research Insight
UK Medical Research Council scientists create world’s first synthetic...
Scientists at the UK's Medical Research Council (MRC) have created the world's first enzymes made from artificial genetic material, which are capable of...
Research Insight
Hilleman signs MoU with Bangladesh firms to develop oral...
Hilleman Laboratories, a joint venture of Merck and Wellcome Trust, has signed a memorandum of understanding (MoU) with Bangladesh-based icddr,b and Incepta Vaccine to develop...
Research Insight
FDA approves Amgen’s BLA for high cholesterol treatment evolocumab
Amgen has received approval for review from US Food and Drug Administration (FDA) for its evolocumab to treat high cholesterol. The FDA...
Research Insight
Takeda and GE Healthcare partner to develop therapeutic drugs...
Japan-based Takeda Pharmaceutical has signed an alliance agreement with GE Healthcare for research and development of hepatic fibrosis. Hepatic fibrosis is an...
Research Insight
ex scientia Ltd. Partners with Sunovion Pharmaceuticals Inc. to...
exscientia Ltd. the polypharmacology driven drug discovery company announced today that they have signed an agreement with Sunovion Pharmaceuticals Inc. to collaborate on...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.